Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Journal Scan / Research · August 23, 2023

Risk Assessment of Kidney Disease Progression and Efficacy of SGLT2 Inhibition in Patients With Type 2 Diabetes

Diabetes Care

 

Additional Info

Disclosure statements are available on the authors' profiles:

Diabetes Care
Risk Assessment of Kidney Disease Progression and Efficacy of SGLT2 Inhibition in Patients With Type 2 Diabetes
Diabetes Care 2023 Aug 09;[EPub Ahead of Print], FA Moura, DD Berg, A Bellavia, JP Dwyer, O Mosenzon, BM Scirica, SD Wiviott, DL Bhatt, I Raz, MW Feinberg, E Braunwald, DA Morrow, MS Sabatine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading